1. Home
  2. EFC vs XERS Comparison

EFC vs XERS Comparison

Compare EFC & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EFC
  • XERS
  • Stock Information
  • Founded
  • EFC 2007
  • XERS 2005
  • Country
  • EFC United States
  • XERS United States
  • Employees
  • EFC N/A
  • XERS N/A
  • Industry
  • EFC Real Estate
  • XERS Biotechnology: Pharmaceutical Preparations
  • Sector
  • EFC Finance
  • XERS Health Care
  • Exchange
  • EFC Nasdaq
  • XERS Nasdaq
  • Market Cap
  • EFC 1.4B
  • XERS 1.3B
  • IPO Year
  • EFC 2010
  • XERS 2018
  • Fundamental
  • Price
  • EFC $13.43
  • XERS $7.49
  • Analyst Decision
  • EFC Strong Buy
  • XERS Strong Buy
  • Analyst Count
  • EFC 7
  • XERS 7
  • Target Price
  • EFC $14.46
  • XERS $8.00
  • AVG Volume (30 Days)
  • EFC 1.3M
  • XERS 2.0M
  • Earning Date
  • EFC 11-05-2025
  • XERS 11-07-2025
  • Dividend Yield
  • EFC 11.62%
  • XERS N/A
  • EPS Growth
  • EFC N/A
  • XERS N/A
  • EPS
  • EFC 1.24
  • XERS N/A
  • Revenue
  • EFC $312,485,000.00
  • XERS $246,025,000.00
  • Revenue This Year
  • EFC N/A
  • XERS $43.89
  • Revenue Next Year
  • EFC $15.82
  • XERS $20.40
  • P/E Ratio
  • EFC $10.84
  • XERS N/A
  • Revenue Growth
  • EFC 10.76
  • XERS 35.62
  • 52 Week Low
  • EFC $11.12
  • XERS $2.69
  • 52 Week High
  • EFC $14.40
  • XERS $8.03
  • Technical
  • Relative Strength Index (RSI)
  • EFC 44.99
  • XERS 55.56
  • Support Level
  • EFC $13.40
  • XERS $7.56
  • Resistance Level
  • EFC $13.94
  • XERS $7.89
  • Average True Range (ATR)
  • EFC 0.17
  • XERS 0.24
  • MACD
  • EFC -0.06
  • XERS -0.12
  • Stochastic Oscillator
  • EFC 4.96
  • XERS 13.60

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

Share on Social Networks: